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Risk Assessment:
Bridging the Gap
between Prediction
and Experimentation
Much of modern science concen-
trates on protecting people from
potentially harmful chemicals, such as
pesticides and herbicides. Safeguarding
humans from unhealthy exposures usually
includes two problematic steps. First,
humans often experience low-level expo-
sures to a compound, but human risk
must be determined from experiments
that employ high-level exposures. Second,
scientists must extrapolate from a chemi-
cal's effect on rodents-the traditional
experimental subjects-to humans. The
NIEHS Laboratory of Computational
Biology and Risk Analysis (CoBRA) is
working to solve the problems associated
with these steps by designing models to
interpret the available data, so that the
resulting knowledge can be applied to
risk-prediction models.
Designing such a model for a specific
system-for example, a particular com-
pound's carcinogenic characteristics-
involves a multistep approach. According
to Christopher J. Portier, chief of
CoBRA, "We start with existing models.
Never reinvent the wheel-that's my
belief." Portier and his colleagues search
the scientific literature for information on
that particular system. Existing models of
how a system works and additional infor-
mation from the literature can be com-
bined to form a modified model.
Whenever possible, such a
model quantifies each step
in a system. Portier says his
laboratory's models use
any and all" mathematics,
including simple, curve-fit-
ting techniques, image-analysis
techniques, neural networks, non-
linear dynamic systems, standard geome-
try, chaos models, and sto- gA A
chastic models. After
arranging a model's steps 0
and transforming them
into mathematical equa-
tions, Portier and his col-
leagues write a computer
program that runs the
available data through the
model. The program helps
answer a critical question:
do the available data make
sense, given the model. If
the answer is no, the
investigators reject the
model; ifthe answer is yes,
the investigators conclude ChristopherJ. P
that the model may be
accurate-until new data force them to
do further fine-tuning or even start over.
Making use of such models depends
on collaboration. "A mathematician who
sits in an office and does modeling all day
without talking to anyone is going to
develop a lot ofnice models that no one's
going to use," Portier says. "Part of the
utility is tying models to what researchers
themselves are saying. We need to inter-
act with them, to get their ideas." In addi-
Io
Putting numbers into pictures. Researchers in the Laboratory of Computational Biology and Risk Analysis
are using information on howthe cell cycle is controlled to develop baseline mathematical models for risk
assessment.
tion to a wide range of contacts at the
NIEHS, CoBRA researchers are collabo-
rating with a variety of other groups,
including the EPA, the National
Toxicology Program (NTP), and foreign
governments, including those of
Australia, Finland, and Korea.
All CoBRA projects focus on three
questions: how do you predict human
risk from available data,
what is the overall quality
of the resulting predic-
tions, and what data
should be collected by
the NTP to make even
better predictions in the
future. Two general areas
of research at CoBRA-
development of new
methods and model-
directed designs-are
providing improved
answers to these funda-
mental questions.
rtier New Methods
Improved knowledge
about human risk often comes from new
methods of data analysis. In some cases,
new methods may be developed to
improve the way that existing data can be
analyzed. In other cases, new methods
must be developed to handle novel
approaches.
"New techniques, new methods, and
new data emerge constantly," Portier
says, "but it's not always clear how they
can be used in risk assessment. We want
to understand their utility. Part of that
sometimes means we have to go back to
< the researchers and say, 'You're collecting
the wrong data; this is really what we
need. Can you do this?'. Another part of
it is helping the researchers get better
information for use in the regulatory
arena and, at the same time, understand-
ing what the data might mean for human
health;" for instance, figuring out what
new biochemical findings about the cell
cycle might mean for risk assessment.
Hisham El-Masri, a postdoctoral
trainee at CoBRA, says, "We are working
to incorporate all phases of the cell
cycle-starting from GO' GI, S, G2 and
M-into a model that describes the tran-
sition of cells from one phase to the
next." The model will include known
biochemical steps that trigger a cell to
move from one phase to another. So far,
El-Masri has concentrated on modeling
specific pieces ofthe cell cycle. For exam-
ple, one piece models the effect ofgrowth
factors on the transition from GO' the
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resting phase, to GI, and another models
the effect of several proteins-cyclins,
cdcs and cdks-on the transition from
GI to S (the stop phase). Eventually, El-
Masri and Portier expect to combine sev-
eral of these smaller models into a com-
plete model of the cell cycle, which will
be compared against experimental data. If
the model makes sense in terms of the
available data, it could be used in risk
assessment-particularly for chemicals
that affect cell division.
Building a quantitative model of cell-
cycle kinetics may provide several benefits.
It will help scientists to understand how
the current breakthroughs in the signaling
process are linked together, creating a flow
chart, of sorts, of the controls of the cell
cycle. The model will also show how spe-
cific gene mutations affect the cell cycle.
The cell-cycle model will then be incorpo-
rated into a comprehensive model of car-
cinogenesis. For example, El-Masri says,
"We can start with a chemical like dioxin
and then follow it all the way down to its
effect on the distribution of cells in each
phase. That could be quan-
titatively incorporated into
a risk assessment for the
effect ofdioxin on cell pro-
liferation."
Design Issues
Issues surrounding how to
set up experiments and
which experiments to per-
form play a fundamental
role in advances of both >
existing and new approach-
es. CoBRA researchers
believe that an experi-
ment's design must meet-
two criteria. First, it must Greg Blumenthal
be scientifically clean,
meaning it must produce a clear answer
to a specific question. Second, Portier
says, "Ifthere is a positive finding from a
study, a regulatory agency should be able
to use that information in the assessment
of human risks from human exposures
and talk about whether the chemical is
going to be an important problem in the
environment. It's clear that we want our
mechanistic data to be ofutility to [such
agencies] .
At the NIEHS, any researcher work-
ing with a chemical that has been nomi-
nated to the NTP for testing who wants
help with design issues can turn to the
Toxicokinetics Group within CoBRA.
The group routinely meets with 15-20
NIEHS scientists who form the
Toxicokinetics Faculty holds monthly
meetings to go over experimental proto-
cols, with emphasis on toxicokinetics-
the quantitative description of the
absorption, distribution, metabolism,
and elimination of toxic
chemicals.
The Toxicokinetics
Group investigates two
categories of chemicals:
chemicals that were nomi-
nated to the NTP before
the faculty's existence, and
newly nominated ones.
For prefaculty chemicals
that are nearly ready for
peer review of the NTP's
technical reports on them,
toxicokinetics can be used
to help explain the sex and
species differences in
effects caused by a chemi- Hisham El-Mas
cal. Greg Blumenthal, a
CoBRA trainee and executive secretary of
the faculty, says, "On the chemicals in
the earlier stages, toxicokinetic modeling
is very valuable as a tool in helping design
the toxicology, helping
to set it up correctly.
The toxicology studies
are big, ungainly
things that you don't
iwant to go through
twice. Toxicokinetic
modeling is relatively
quick and cheap, and it
gives a fairly decent
amount of information
in helping to put the
y V\ >l0/.\toxicology study togeth-
'i1ls v\) ' S ercorrectly."
Ten years ago, the 0 - ; NTP concentrated on
toxicity studies such as
cancer bioassays and
immunotoxic effects. In other words, the
NTP examined whata chemical did, but
;ri
not how it did it. In the last five years,
the NTP has started looking for the
mechanisms behind a chemical's effects,
which relies precisely on the strength of
Ig ., =toxicokinetics data and
If jModeling.
Future Goals
According to Portier,
} risk-assessment managers
need better information
because "95% of risk
assessment is done on
the back of an enve-
lope-someone has very
limited information, has
to make a decision
today, and uses the best
judgment from the avail-
able information." In
the future, Portier thinks
that CoBRA could pro-
vide a risk-assessment manager with the
best technical guidance and easily accessi-
ble analytical tools to make a very quick
decision on a compound's risk.
Nevertheless, so many potentially
dangerous chemicals exist that they can-
not all be tested in any reasonable peri-
od of time. The U.S. Toxic Substances
Control Act includes nearly 70,000
entries, but the NTP can test only
about 40 chemicals a year. So it would
take more than 1,700 years to test them
all and the list grows by about 2,000
chemicals each year. Fortunately, know-
ing the potential risk of one chemical
helps scientists predict the risk of oth-
ers. Says Portier, "Certain compounds
have patterns of toxicity response that
are similar. The ideal would be to start
isolating these patterns to aid in making
decisions."
Mike May
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